Projects per year
Fingerprint
Dive into the research topics where Countermeasures Development & Evaluation Scientific Leaders is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
-
Safety and immunogenicity of nasal inoculation with recombinant Neisseria lactamica expressing Factor H binding protein and Neisseria Adhesin A.
Laver, J. R. (PI), Lucidarme, J. (CoPI), Dale, A. P. (CoPI), Gorringe, A. (CoPI), Faust, S. N. (CoPI), Cleary, D. (CoPI), Read, R. C. (CoPI) & Borrow, R. (CoPI)
1/05/24 → 30/04/29
Project: Research
-
MICA:The immunogenicity of combined pertussis-containing vaccine (Tdap) for HIV-infected pregnant women and their newborns-A Randomized Clinical Trial
Doare, K. L. (PI), Heath, P. T. (CoPI), Gorringe, A. (CoPI), Abu-Raya, B. (CoPI), Sadarangani, M. (CoPI) & Sadarangani, M. M. (CoPI)
31/12/19 → 29/06/23
Project: Research
Research output
-
A hyperimmune ovine antibody-based therapeutic candidate against Crimean–Congo haemorrhagic fever virus targeted to the Gn and Gc glycoproteins: high antibody levels with neutralization activity but lack of protective efficacy in a mouse model
Kennedy, E., Findlay-Wilson, S., Webster, S., Rajabzadeh, A., Fotheringham, S., Easterbrook, L., Chambers, A., Aksular, M., Possee, R., Smith, S., Pope, N., Griffiths, A., Arnold, U., Jackson, D., Ruedas-Torres, I., Salguero, F. J. & Dowall, S., 15 Apr 2026, In: Antibody Therapeutics. 9, 2, p. 179-190 12 p.Research output: Contribution to journal › Article › peer-review
Open Access -
An adenoviral-vectored vaccine protects mice against aerosol challenge with Yersinia pestis
Dold, C., Silva-Reyes, L., Kim, Y. C., Blackwell, L., Campos, P., Linder, A., Bridges-Webb, A., Kasanyinga, M., Lopez-Camacho, C., Challis, A., Hatch, G., Fotheringham, S., Beernink, P. T., Hill, A. V., Funnell, S. G. P., Pollard, A. J. & Rollier, C. S., 23 Feb 2026, (Accepted/In press) In: Molecular Therapy. 34, 6, p. 3518-3534 17 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
A novel two-hit murine model of inhaled occupational exposure-induced lung disease
Barahona, M., DeBie, A., Dean, L. S., Klemp, B., Jones, K., Oyewole, E. O., Wahl, M., Pauly, M., McDermott, C., Salguero, F. J., Anderson, G. B., Henao-Tamayo, M. & Nordgren, T. M., Jul 2026, In: Physiological Reports. 14, 13, e71019.Research output: Contribution to journal › Article › peer-review
Open Access
Impacts
-
An Open Innovation model to support research on antimicrobial resistance and difficult to treat infections
Sutton, J. (Participant) & Hind, C. (Participant)
Impact: Health impacts, Social impacts
File -
Application of the UKHSA antimicrobial resistance Open Innovation model to support Pathways to Antimicrobial Clinical Efficacy (PACE)
Hind, C. (Participant) & Sutton, J. (Participant)
Impact: Health impacts
File -
Assessing COVID-19 therapeutics for efficacy against new SARS-CoV-2 variants as they emerge
Tree, J. (Participant), Horton, A. (Participant), Wand, M. (Participant), Cano Cejas, I. (Participant), Evans, E. (Participant) & Sutton, J. (Participant)
Impact: Health impacts